Published in Am J Geriatr Psychiatry on September 01, 2011
Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry (2012) 2.94
Of mice and men: modelling post-stroke depression experimentally. Br J Pharmacol (2014) 0.93
Abnormal functional connectivity of amygdala in late-onset depression was associated with cognitive deficits. PLoS One (2013) 0.88
Mild cognitive impairment, poor episodic memory, and late-life depression are associated with cerebral cortical thinning and increased white matter hyperintensities. Front Aging Neurosci (2014) 0.87
Perceived stress is associated with subclinical cerebrovascular disease in older adults. Am J Geriatr Psychiatry (2013) 0.86
Biological basis of late life depression. Curr Psychiatry Rep (2012) 0.85
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics. Biochem Pharmacol (2013) 0.80
Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression. Am J Geriatr Psychiatry (2013) 0.79
Molecular Neurobiology and Promising New Treatment in Depression. Int J Mol Sci (2016) 0.78
Involvement of brain-derived neurotrophic factor in late-life depression. Am J Geriatr Psychiatry (2013) 0.78
Amygdala network dysfunction in late-life depression phenotypes: Relationships with symptom dimensions. J Psychiatr Res (2015) 0.77
Brain structure across the lifespan: the influence of stress and mood. Front Aging Neurosci (2014) 0.76
Recent advances in neuroimaging biomarkers in geriatric psychiatry. Curr Psychiatry Rep (2013) 0.76
Organic bases of late-life depression: a critical update. J Neural Transm (Vienna) (2013) 0.75
Applications of magnetic resonance imaging for treatment-resistant late-life depression. Dialogues Clin Neurosci (2015) 0.75
Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression. Am J Geriatr Psychiatry (2017) 0.75
Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging (1997) 16.80
Automated model-based tissue classification of MR images of the brain. IEEE Trans Med Imaging (1999) 8.33
Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature (1994) 5.55
Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci (1997) 5.41
Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry (2001) 5.11
A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain (1998) 4.84
Neuroimaging studies of mood disorders. Biol Psychiatry (2000) 3.92
A functional anatomical study of unipolar depression. J Neurosci (1992) 3.85
Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry (2004) 3.85
Automated segmentation of multiple sclerosis lesions by model outlier detection. IEEE Trans Med Imaging (2001) 3.00
Dissociable neural responses to facial expressions of sadness and anger. Brain (1999) 2.94
MRI-defined vascular depression. Am J Psychiatry (1997) 2.92
Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci (1999) 2.52
Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry (2000) 2.01
White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry (2007) 2.00
Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport (1998) 2.00
Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology (2004) 1.82
Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med (2000) 1.77
A unifying framework for partial volume segmentation of brain MR images. IEEE Trans Med Imaging (2003) 1.73
Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry (2008) 1.67
Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67
Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry (1993) 1.61
White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry (2003) 1.46
Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry (2005) 1.41
Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res (2005) 1.39
Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci (2003) 1.22
Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology (2000) 1.18
Amygdala volume marks the acute state in the early course of depression. Biol Psychiatry (2008) 1.07
Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol Med (2007) 1.07
The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults. Psychiatry Res (2007) 1.02
Amygdalae morphometry in late-life depression. Int J Geriatr Psychiatry (2009) 1.01
Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging (1991) 1.01
Arteriosclerotic depression. Med Hypotheses (1995) 0.99
Age-dependent reduction of amygdala volume in bipolar disorder. Psychiatry Res (2008) 0.93
Delineation of two genetic pathways to major depression. Biol Psychiatry (2008) 0.92
Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression. J Psychiatr Res (2009) 0.90
Age of onset of depression and quantitative neuroanatomic measures: absence of specific correlates. Psychiatry Res (1999) 0.81
Amygdala volumes in a sample of current depressed and remitted depressed patients and healthy controls. J Affect Disord (2010) 0.80
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med (2008) 5.34
The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology (2005) 4.44
Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry (2012) 2.94
Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples. Alzheimers Dement (2006) 2.51
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2008) 2.32
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J (2007) 2.12
Reducing suicidal ideation in depressed older primary care patients. J Am Geriatr Soc (2006) 2.11
Head injury in early adulthood and the lifetime risk of depression. Arch Gen Psychiatry (2002) 1.97
Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression. Biol Psychiatry (2006) 1.94
Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry (2006) 1.92
Depression treatment preferences in older primary care patients. Gerontologist (2006) 1.92
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Greater risk of dementia when spouse has dementia? The Cache County study. J Am Geriatr Soc (2010) 1.73
Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry (2006) 1.73
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry (2010) 1.72
Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. Psychiatry Res (2008) 1.66
Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol (2011) 1.63
Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc (2010) 1.60
Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry (2004) 1.55
Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation (2004) 1.55
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiol Drug Saf (2005) 1.52
Prefrontal neuropsychological predictors of treatment remission in late-life depression. Neuropsychopharmacology (2004) 1.48
Vascular risk factors and cognitive decline among elderly male twins. Neurology (2006) 1.47
Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. J Clin Psychiatry (2005) 1.47
Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry (2004) 1.46
White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry (2003) 1.46
The persistence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2004) 1.46
Persistent mild cognitive impairment in geriatric depression. Int Psychogeriatr (2006) 1.45
Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry (2008) 1.45
Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology (2004) 1.44
Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med (2008) 1.42
Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs). Evid Rep Technol Assess (Full Rep) (2007) 1.42
Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression. Am J Psychiatry (2008) 1.42
Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry (2005) 1.39
The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach. Psychopharmacol Bull (2002) 1.39
Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res (2005) 1.39
Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry (2007) 1.35
Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. AJR Am J Roentgenol (2003) 1.34
The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med (2003) 1.33
Midlife activity predicts risk of dementia in older male twin pairs. Alzheimers Dement (2008) 1.32
Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry (2002) 1.31
Aging, gender, and the elderly adult brain: an examination of analytical strategies. Neurobiol Aging (2006) 1.30
Diffusion tensor measures of the corpus callosum in adolescents with adolescent onset alcohol use disorders. Alcohol Clin Exp Res (2008) 1.29
Cortical white matter microstructural abnormalities in bipolar disorder. Neuropsychopharmacology (2005) 1.25
Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. Am J Geriatr Psychiatry (2005) 1.23
Hippocampal volume and incident dementia in geriatric depression. Am J Geriatr Psychiatry (2002) 1.22
Profiles of depressive symptoms in older adults diagnosed with major depression: latent cluster analysis. Am J Geriatr Psychiatry (2009) 1.21
Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry (2011) 1.21
Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry. Twin Res Hum Genet (2006) 1.19
A preliminary metabolomic analysis of older adults with and without depression. Int J Geriatr Psychiatry (2007) 1.19
The vascular depression subtype: evidence of internal validity. Biol Psychiatry (2008) 1.19
The incidence of mental and behavioral disturbances in dementia: the cache county study. J Neuropsychiatry Clin Neurosci (2003) 1.18
Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry (2008) 1.18
Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors. Genet Med (2007) 1.17
Calcium and vitamin D intakes may be positively associated with brain lesions in depressed and nondepressed elders. Nutr Res (2008) 1.16
Decision-making and risk aversion among depressive adults. J Behav Ther Exp Psychiatry (2008) 1.16
Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J Am Geriatr Soc (2011) 1.15
The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. Biol Psychiatry (2006) 1.15
Neurocognitive correlates of response to treatment in late-life depression. Am J Geriatr Psychiatry (2008) 1.15
National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain. Ann Intern Med (2015) 1.12
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis (2003) 1.12
Structural integrity of the uncinate fasciculus in geriatric depression: Relationship with age of onset. Neuropsychiatr Dis Treat (2007) 1.11
Localization of age-associated white matter hyperintensities in late-life depression. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.11
Three-year incidence of first-onset depressive syndrome in a population sample of older adults: the Cache County study. Am J Geriatr Psychiatry (2006) 1.10
Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature. CNS Drugs (2010) 1.10
Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial. Am J Med Genet A (2003) 1.10
Psychosocial and clinical predictors of unipolar depression outcome in older adults. Int J Geriatr Psychiatry (2002) 1.10
Contribution of depression to cognitive impairment and dementia in older adults. Neurologist (2007) 1.09
Frontal white matter anisotropy and antidepressant remission in late-life depression. PLoS One (2008) 1.09
Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. Alzheimers Dement (2009) 1.08
Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol Med (2007) 1.07